Cargando…
Pragmatic trials: ignoring a mediator and adjusting for confounding
OBJECTIVES: In pragmatic trials, the new treatment is compared with usual care (heterogeneous control arm) that makes the comparison of the new treatment with each treatment within the control arm more difficult. The usual assumption is that we can fully capture the relations between different quant...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425675/ https://www.ncbi.nlm.nih.gov/pubmed/30894221 http://dx.doi.org/10.1186/s13104-019-4188-1 |
_version_ | 1783404884831240192 |
---|---|
author | Pericleous, Paraskevi |
author_facet | Pericleous, Paraskevi |
author_sort | Pericleous, Paraskevi |
collection | PubMed |
description | OBJECTIVES: In pragmatic trials, the new treatment is compared with usual care (heterogeneous control arm) that makes the comparison of the new treatment with each treatment within the control arm more difficult. The usual assumption is that we can fully capture the relations between different quantities. In this paper we use simulation to assess the performance of statistical methods that adjust for confounding when the assumed relations are not true. The true relations contain a mediator and heterogeneity with or without confounding, but the assumption is that there is no mediator and that confounding and heterogeneity are fully captured. The statistical methods that are compared include multivariable logistic regression, propensity score, disease risk score, inverse probability weighting, doubly robust inverse probability weighting and standardisation. RESULTS: The misconception that there is no mediator can cause to misleading comparative effectiveness of individual treatments when a method that estimates the conditional causal effect is used. Using a method that estimates the marginal causal effect is a better approach, but not for all scenarios. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-019-4188-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6425675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64256752019-04-01 Pragmatic trials: ignoring a mediator and adjusting for confounding Pericleous, Paraskevi BMC Res Notes Research Note OBJECTIVES: In pragmatic trials, the new treatment is compared with usual care (heterogeneous control arm) that makes the comparison of the new treatment with each treatment within the control arm more difficult. The usual assumption is that we can fully capture the relations between different quantities. In this paper we use simulation to assess the performance of statistical methods that adjust for confounding when the assumed relations are not true. The true relations contain a mediator and heterogeneity with or without confounding, but the assumption is that there is no mediator and that confounding and heterogeneity are fully captured. The statistical methods that are compared include multivariable logistic regression, propensity score, disease risk score, inverse probability weighting, doubly robust inverse probability weighting and standardisation. RESULTS: The misconception that there is no mediator can cause to misleading comparative effectiveness of individual treatments when a method that estimates the conditional causal effect is used. Using a method that estimates the marginal causal effect is a better approach, but not for all scenarios. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-019-4188-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-20 /pmc/articles/PMC6425675/ /pubmed/30894221 http://dx.doi.org/10.1186/s13104-019-4188-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Note Pericleous, Paraskevi Pragmatic trials: ignoring a mediator and adjusting for confounding |
title | Pragmatic trials: ignoring a mediator and adjusting for confounding |
title_full | Pragmatic trials: ignoring a mediator and adjusting for confounding |
title_fullStr | Pragmatic trials: ignoring a mediator and adjusting for confounding |
title_full_unstemmed | Pragmatic trials: ignoring a mediator and adjusting for confounding |
title_short | Pragmatic trials: ignoring a mediator and adjusting for confounding |
title_sort | pragmatic trials: ignoring a mediator and adjusting for confounding |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425675/ https://www.ncbi.nlm.nih.gov/pubmed/30894221 http://dx.doi.org/10.1186/s13104-019-4188-1 |
work_keys_str_mv | AT pericleousparaskevi pragmatictrialsignoringamediatorandadjustingforconfounding |